Recursion Pharmaceuticals Inc (RXRX) — Technical state

As of 2026-09-18 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +17.5% vs the 50-day and +6.2% vs the 200-day average, 46.7% below the 52-week high and +38.3% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-09-18

Quick answers

What is the current Closelook signal on RXRX?

Recovery attempt under the 200-day — Trades +17.5% vs the 50-day and +6.2% vs the 200-day average, 46.7% below the 52-week high and +38.3% off the 52-week low. Computed from daily closes. As of 2026-09-18; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is RXRX above its 50-day and 200-day moving averages?

As of 2026-09-18, Recursion Pharmaceuticals Inc trades +17.5% above its 50-day and +6.2% above its 200-day average, with the 20-day +12.7% away.

How far is RXRX from its 52-week high?

46.7% below the 52-week high and 38.3% above the 52-week low, as of 2026-09-18.

Mentioned on Closelook

Where RXRX appears in the diary — 2 pieces, newest first. Every link is our own writing.

Long reads

  • Pattern 03 — NVIDIA Strategic Authority InvestmentReport · 12 May 2026The 16-Event Timeline (2023-07-12 → 2026-05-12) 2024 2025 2026 RXRX 23-07 ARM 23-09 APLD 24-09 NBIS 24-12 MRVL 25-03 CRWV 25-03 INTC 25-09 NOK 25-10 SNPS 25-12 LITE COHR 26-03 IREN 26-05 GLW 26-05 exit RXRX exit APLD exit ARM Tier 1 …

Dailies

Related in the Closelook universe

same Closelook index seat first, then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.